Investors

INMODE INVESTOR PORTAL

CORPORATE OVERVIEW


InMode Ltd. (Nasdaq: INMD) is a leading global provider of innovative medical technologies. InMode develops, manufacturers, and markets devices harnessing novel radio-frequency (RF) based devices that strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology and ophthalmology.

COMPANY HIGHLIGHTS

STOCK PERFORMANCE

NASDAQ : INMD

PRICE

$0

CHANGE

0(0%)

VOLUME

0

Copyright Nasdaq. Latest trading day: .

Press Releases

InMode to Report Q2 2026 Financial Results on Aug 5, 2026, Expects Q2 Revenue Between $95.2M-$95.4M, Reiterates FY 2026 Revenue Guidance Between $365M-$375M

InMode Confirms Receipt of Unsolicited Proposal

InMode Confirms Receipt of Unsolicited Proposal

Financials & Filings

SEC FILINGS

Contact Us

Contact Us